The role of coinfections in HIV epidemic trajectory and positive prevention: A systematic review and meta-analysis

AIDS

Volumn 25, Issue 13, 2011, Pages 1559-1573

  Barnabas, Ruanne V ^a,c   Webb, Emily L ^b   Weiss, Helen A ^b   Wasserheit, Judith N ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

herpes simplex virus 2; HIV; HIV coinfections; malaria; tuberculosis; viral load

Indexed keywords

ACICLOVIR; ETHAMBUTOL; ETHAMBUTOL PLUS ISONIAZID; ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; ISONIAZID PLUS RIFAMPICIN; STREPTOMYCIN; VALACICLOVIR;

DISEASE ASSOCIATION; DISEASE TRANSMISSION; EMBASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLNESS TRAJECTORY; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; MALARIA; MEDLINE; MIXED INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; TUBERCULOSIS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HERPES GENITALIS; HIV INFECTIONS; HUMANS; MALARIA; TUBERCULOSIS; VIRAL LOAD;

EID: 80051791963     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283491e3e     Document Type: Review

References (73)

1. UNAIDS. AIDS epidemic update. Geneva: WHO; 2009:100.
2. Buve A, Carael M, Hayes RJ, Auvert B, Ferry B, Robinson NJ, et al. The multicentre study on factors determining the differential spread of HIV in four African cities: summary and conclusions. AIDS 2001;15(Suppl 4):S127-S131. (Pubitemid 32913012)
3. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010;375:2092-2098.
4. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342:921-929. (Pubitemid 30177052)
5. Glynn JR, Biraro S, Weiss HA. Herpes simplex virus type2: a key role in HIV incidence. AIDS 2009;23:1595-1598.
6. Bunnell R, Mermin J, De Cock KM. HIV prevention for a threatened continent: implementing positive prevention in Africa. JAMA 2006;296:855-858. (Pubitemid 44223108)
7. WHO. Tuberculosis Facts. 2009. http://www.who.int/tb/publi cations/2009/tbfactsheet-2009update-one-page.pdf.
8. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004;11(Suppl 1):24A-35A. (Pubitemid 38529332)
9. Grimwade K, French N, Mbatha DD, Zungu DD, Dedicoat M, Gilks CF. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. AIDS 2004;18:547-554. (Pubitemid 38365884)
10. French N, Nakiyingi J, Lugada E, Watera C, Whitworth JA, Gilks CF. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS 2001;15:899-906. (Pubitemid 32424393)
11. Walson JL, John-Stewart G. Treatment of helminth co-infection in individuals with HIV-1: a systematic review of the literature. PLoS Negl Trop Dis 2007;1:e102.
12. Higgins J P T, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. Chichester, UK: John Wiley & Sons, Ltd.; 2006.
13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
14. French N. Pneumoccal disease and its prevention by vaccination in HIV-infected Ugandan adults. Liverpool: University of Liverpool; 2004.
15. Phiri S, Hoffman IF, Weiss HA, Martinson F, Nyirenda N, Kamwendo D, et al. Impact of aciclovir on ulcer healing, lesional, genital and plasma HIV-1 RNA among patients with genital ulcer disease in Malawi. Sex Transm Infect 2010;86:345-352.
16. Tanton C, Weiss HA, Rusizoka M, Legoff J, Changalucha J, Baisley K, et al. Long-term impact of acyclovir suppressive therapy on genital and plasma HIV RNA in Tanzanian women: a randomized controlled trial. J Infect Dis 2010;201:1285-1297.
17. Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Masyuk LA, Kutsyna GA. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving antituberculosis therapy under DOTS. Int Immunopharmacol 2008;8:845-851.
18. Manoff SB, Farzadegan H, Munoz A, Astemborski JA, Vlahov D, Rizzo RT, et al. The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J Infect Dis 1996;174:299-308. (Pubitemid 26251415)
19. Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-1278. (Pubitemid 126449644)
20. Chen X, Xiao B, Shi W, Xu H, Gao K, Rao J, Zhang Z. Impact of acute vivax malaria onthe immune system and viral load of HIV-positive subjects. Chin Med J (Engl) 2003;116:1810-1820. (Pubitemid 38159877)
21. Barbour JD, Sauer MM, Sharp ER, Garrison KE, Long BR, Tomiyama H, et al. HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts. PLoS One 2007;2:e1080.
22. Day JH, Grant AD, Fielding KL, Morris L, Moloi V, Charalambous S, et al. Does tuberculosis increase HIV load? J Infect Dis 2004;190:1677-1684. (Pubitemid 39411019)
23. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, et al. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002;16:75-83. (Pubitemid 34062184)
24. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, et al. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Natl Med J India 2008;21:3-8. (Pubitemid 351420139)
25. Tatfeng YM, Ihongbe JC, Okodua M, Oviasogie E, Isibor J, Tchougang S, et al. CD4 count, viral load and parasite density of HIV positive individuals undergoing malaria treatment with dihydroartemisinin in Benin City, Edo state, Nigeria. J Vector Borne Dis 2007;44:111-115. (Pubitemid 47233911)
26. Toossi Z, Mayanja-Kizza H, Hirsch CS, Edmonds KL, Spahlinger T, Hom DL, et al. Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol 2001;123:233-238. (Pubitemid 32174774)
27. Toossi Z, Mayanja-Kizza H, Lawn SD, Hirsch CS, Lupo LD, Butera ST. Dynamic variation in the cellular origin of HIV type 1 during treatment of tuberculosis in dually infected subjects. AIDS Res Hum Retroviruses 2007;23:93-100. (Pubitemid 46214177)
28. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558. (Pubitemid 34746062)
29. Light RJ, Pillemer DB. Summing up. The science of reviewing research. Cambridge, MA: Harvard University Press; 1984.
30. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997;315:629-634. (Pubitemid 27387172)
31. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Magaret A, et al. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men. AIDS 2009;23:479-483.
32. Mawa PA, Pickering JM, Miiro G, Namujju PB, Watera C, Anyaegani G, et al. The effect of tuberculin skin testing on viral load and antimycobacterial immune responses in HIV-1-infected Ugandan adults. Int J Tuberc Lung Dis 2004;8:586-592. (Pubitemid 38625064)
33. Wolday D, Hailu B, Girma M, Hailu E, Sanders E, Fontanet AL. Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohortof HIV-positive Ethiopians. Ethiop Med J 2003;41(Suppl 1):67-73.
34. Hoffman IF, Jere CS, Taylor TE, Munthali P, Dyer JR, Wirima JJ, et al. The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS 1999;13:487-494.
35. Kublin JG, Patnaik P, Jere CS, Miller WC, Hoffman IF, Chimbiya N, et al. Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study. Lancet 2005;365:233-240. (Pubitemid 40138017)
36. Van Geertruyden JP, Mulenga M, Kasongo W, Polman K, Colebunders R, Kestens L, D'Alessandro U. CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria. J Acquir Immune Defic Syndr 2006;43:363-367. (Pubitemid 44674019)
37. Cachay ER, Frost SD, Poon AF, Looney D, Rostami SM, Pacold ME, et al. Herpes simplex virus type 2 acquisition during recent HIV infection does not influence plasma HIV levels. J Acquir Immune Defic Syndr 2008;47:592-596. (Pubitemid 351442015)
38. Mole L, Ripich S, Margolis D, Holodniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-770. (Pubitemid 27360547)
39. Chu L, Jiamton S, Pepin J, Cowan F, Mahakkanukrauh B, Suttent R, et al. Association between HSV-2 and HIV-1 viral load in semen, cervico-vaginal secretions and genital ulcers of Thai men and women. Int J STD AIDS 2006;17:681-686. (Pubitemid 44611149)
40. Gray RH, Li X, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F, et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a generalpopulation cohort of Rakai, Uganda. J Infect Dis 2004;189:1209-1215. (Pubitemid 38457245)
41. Duffus WA, Mermin J, Bunnell R, Byers RH, Odongo G, Ekwaru P, Downing R. Chronic herpes simplex virus type-2 infection and HIV viral load. Int J STD AIDS 2005;16:733-735. (Pubitemid 41659532)
42. Cachay ER, Frost SD, Richman DD, Smith DM, Little SJ. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. J Infect Dis 2007;195:1270-1277. (Pubitemid 46649611)
43. Serwadda D, Gray RH, Sewankambo NK, Wabwire-Mangen F, Chen MZ, Quinn TC, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003;188:1492-1497. (Pubitemid 37523934)
44. Baeten JM, Strick LB, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 2008;198:1804-1808.
45. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010;362:427-439.
46. Delany S, Mlaba N, Clayton T, Akpomiemie G, Capovilla A, Legoff J, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS 2009;23:461-469.
47. Dunne EF, Whitehead S, Sternberg M, Thepamnuay S, Leelawiwat W, McNicholl JM, et al. Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV-and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr 2008;49:77-83.
48. Nagot N, Ouedraogo A, Foulongne V, Konate I, Weiss HA, Vergne L, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007;356:790-799. (Pubitemid 46294611)
49. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002;186:1718-1725. (Pubitemid 35463503)
50. Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 2007;196:1500-1508. (Pubitemid 351411987)
51. Mayaud P, Legoff J, Weiss HA, Gresenguet G, Nzambi K, Bouhlal H, et al. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial. J Infect Dis 2009;200:216-226.
52. Paz-Bailey G, Sternberg M, Puren AJ, Markowitz LE, Ballard R, Delany S, et al. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. Infect Dis 2009;200:1039-1049.
53. Lopez-Gatell H, Cole SR, Margolick JB, Witt MD, Martinson J, Phair JP, Jacobson LP. Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence. AIDS 2008;22:1869-1873.
54. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, et al. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 2000;14:1219-1228. (Pubitemid 30420666)
55. Kizza HM, Rodriguez B, Quinones-Mateu M, Mirza M, Aung H, Yen-Lieberman B, et al. Persistent replication of human immunodeficiency virus type 1 despite treatment of pulmonary tuberculosis in dually infected subjects. Clin Diagn Lab Immunol 2005;12:1298-1304. (Pubitemid 41626599)
56. Hung CC, Chen MY, Hsiao CF, Hsieh SM, Sheng WH, Chang SC. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy. AIDS 2003;17:2615-2622.
57. Wallis RS, Nsubuga P, Whalen C, Mugerwa RD, Okwera A, Oette D, et al. Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial. J Infect Dis 1996;174:727-733. (Pubitemid 26325887)
58. Lawn SD. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. J Infect 2004;48:1-12. (Pubitemid 38072197)
59. Kalou M, Sassan-Morokro M, Abouya L, Bile C, Maurice C, Maran M, et al. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire. J Med Virol 2005;75:202-208. (Pubitemid 40053729)
60. Morris L, Martin DJ, Bredell H, et al. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. J Infect Dis 2003;187:1967-1971. (Pubitemid 36724497)
61. Schon T, Wolday D, Elias D, Melese E, Moges F, Tessema T, et al. Kinetics of sedimentation rate, viral load and TNF-alpha in relation to HIV co-infection in tuberculosis. Trans R Soc Trop Med Hyg 2006;100:483-488. (Pubitemid 43362153)
62. Modjarrad K, Vermund SH. Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis 2010;10:455-463.
63. Modjarrad K, Chamot E, Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008;22:2179-2185.
64. Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, et al. Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk. PLoS One 2010;5:e12598.
65. Fraser C, Hollingsworth TD, Chapman R, de Wolf F, Hanage WP. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci U S A 2007;104:17441-17446. (Pubitemid 350219857)
66. Renia L, Potter SM. Co-infection of malaria with HIV: an immunological perspective. Parasite Immunol 2006;28:589-595. (Pubitemid 44581384)
67. Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, et al. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 2010;375:824-833.
68. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 2009;15:886-892.
69. Del Amo J, Perez-Hoyos S, Hernandez Aguado I, Diez M, Castilla J, Porter K. Impact of tuberculosis on HIV disease progression in persons with well documented time of HIV seroconversion. J Acquir Immune Defic Syndr 2003;33:184-190. (Pubitemid 36793153)
70. Straetemans M, Bierrenbach AL, Nagelkerke N, Glaziou P, van der Werf MJ. The effect of tuberculosis on mortality in HIV positive people: a meta-analysis. PLoS One 2010;5:e15241.
71. Hewitt K, Steketee R, Mwapasa V, Whitworth J, French N. Interactions between HIV and malaria in nonpregnant adults: evidence and implications. AIDS 2006;20:1993-2004. (Pubitemid 44611052)
72. Slutsker L, Marston BJ. HIV and malaria: interactions and implications. Curr Opin Infect Dis 2007;20:3-10. (Pubitemid 46052120)
73. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 2011;3:77ra29.